| |
 |
Professor Chim C Lang, BMSc, MD, FRCP, FRCPE, FACC
Professor of Cardiology, Division of Cardiovascular & Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School
Dundee, United Kingdom |
|
| |
| Biography: |
|
| |
| Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology at University of Dundee. He trained in both cardiology and clinical pharmacology in the UK and in the USA, where he was a Merck Fellow at Vanderbilt University, Nashville, and a Fulbright Scholar at Columbia University, New York. His patient-oriented research takes a multidisciplinary approach to the understanding of the pathophysiology of heart failure and cardiometabolic diseases. He leads an integrated cardiovascular research laboratory dedicated to, and equipped for, the study of cardiac and vasomotor regulation. These techniques are applied to translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases. He sits on the editorial boards of several scientific journals including Cardiovascular Therapeutics (Joint Editor-in-Chief), and Clinical Science (Associate Editor) and Current Clinical Pharmacology. He is Chair of the Heart Failure Working Group of NHS Tayside. |
| |
| Session: |
|
| |
| 21st November 2015 (Saturday) |
 |
09:00-09:30 |
|
| |
| Session II: Early Clinical Research on Asian Diseases |
| Diabetes and Heart Failure: Addressing an Unmet Need through ‘Proof of Concept’ Trials |
| |
|
|
